Trials / Recruiting
RecruitingNCT05437588
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 10 Years – 24 Years
- Healthy volunteers
- Accepted
Summary
This study is dedicated to help identify biomarkers for depression and suicide. The purpose of the study is to better understand these links to improve medical and psychiatric care in the future. This research is also to test the effects of standard treatment of depression on improvement in depressive and suicidal behavior and on biomarkers (e.g. miRNA) for these disorders.
Conditions
- Major Depressive Disorder
- Suicidal Ideas
- Suicide, Attempted
- MDD
- Depression
- Depression, Teen
- Depression and Suicide
- Depression in Adolescence
- Suicide
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Genetic testing | Attempting to identify the genetic biomarker that can identify risk for suicidal ideation and action |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2027-06-29
- Completion
- 2027-06-30
- First posted
- 2022-06-29
- Last updated
- 2025-07-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05437588. Inclusion in this directory is not an endorsement.